ABVC BioPharma raises ~$619k via unregistered share sales to non-U.S. persons

ABVC BIOPHARMA, INC.

On April 30, 2025 sold 724,372 shares for ~$436k to 15 non-U.S. persons under Regulation S.
Additional subscriptions from May 9-13, 2025: 306,041 shares for ~$183,625 from 7 non-U.S. persons.
Each investor transferred voting rights to chairman Eugene Jiang via Voting Rights Proxy Agreement.
Shares are unregistered, restricted for one year, and sold without general solicitation.
Total gross proceeds from both tranches approximate $619,625.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.